Companies / BOC Sciences / Pinatuzumab
BOC Sciences

Pinatuzumab | BOC Sciences

Pinatuzumab is an anti-CD22 monoclonal antibody which has been used in the research of non-Hodgkin lymphoma (NHL).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.